✦ LIBER ✦

Re: Salvage Therapy With Bicalutamide 150 mg in Nonmetastatic Castration-resistant Prostate Cancer

✍ Scribed by Jan Kliment

Book ID: 113612279
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 57 KB
Volume: 59
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2011.03.042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Salvage Therapy With Bicalutamide 150 mg

Salvage Therapy With Bicalutamide 150 mg in Nonmetastatic Castration-resistant Prostate Cancer

✍ Michele Lodde; Louis Lacombe; Yves Fradet 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 337 KB

MP-08.01: Salvage therapy with bicalutam

MP-08.01: Salvage therapy with bicalutamide 150 mg in patients with PSA failure under LHRH therapy or surgical castration for advanced prostate cancer

✍ Y. Fradet 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Immediate Treatment with Bicalutamide 15

Immediate Treatment with Bicalutamide 150 mg as Adjuvant Therapy Significantly Reduces the Risk of PSA Progression in Early Prostate Cancer

✍ W See; P Iversen; M Wirth; D McLeod; L Garside; T Morris 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Casodex (bicalutamide) 150-mg monotherap

Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years

✍ Peter Iversen; Chris J. Tyrrell; Amir V. Kaisary; John B. Anderson; Luc Baert; T 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 871 KB

Bicalutamide (‘Casodex’) 150 mg as

Bicalutamide (‘Casodex’) 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: Results from the randomised Early Prostate Cancer Programme

✍ Chris J. Tyrrell; Heather Payne; William A. See; David G. McLeod; Manfred P. Wir 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 245 KB

BICALUTAMIDE (150 MG) VERSUS PLACEBO AS

BICALUTAMIDE (150 MG) VERSUS PLACEBO AS IMMEDIATE THERAPY ALONE OR AS ADJUVANT TO THERAPY WITH CURATIVE INTENT FOR EARLY NONMETASTATIC PROSTATE CANCER: 5.3-YEAR MEDIAN FOLLOWUP FROM THE SCANDINAVIAN PROSTATE CANCER GROUP STUDY NUMBER 6

✍ IVERSEN, PETER; JOHANSSON, JAN-ERIK; LODDING, PÄR; LUKKARINEN, OLAVI; LUNDMO, PE 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 334 KB

Re: Salvage Therapy With Bicalutamide 150&#xa0;mg in Nonmetastatic Castration-resistant Prostate Cancer

Re: Salvage Therapy With Bicalutamide 150 mg in Nonmetastatic Castration-resistant Prostate Cancer